Fifth Third Bancorp
HUMA icon

Fifth Third Bancorp’s Humacyte HUMA Stock Holding History

Fifth Third Bancorp’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$542 Buy
694
+194
+39% +$180 ﹤0.01% 4227
2026
Q1 		$303 Hold
500
– – ﹤0.01% 4224
2025
Q4 		$480 Hold
500
– – ﹤0.01% 2555
2025
Q3 		$870 Hold
500
– – ﹤0.01% 2545
2025
Q2 		$1.04K Sell
500
-450
-47% -$864 ﹤0.01% 2426
2025
Q1 		$1.62K Hold
950
– – ﹤0.01% 2358
2024
Q4 		$4.8K Hold
950
– – ﹤0.01% 2173
2024
Q3 		$5.17K Buy
950
+450
+90% +$2.97K ﹤0.01% 2177
2024
Q2 		$2.4K Buy
+500
New +$2.6K ﹤0.01% 2245

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Fifth Third Bancorp's HUMA Position: Q2 2026 in Review

Fifth Third Bancorp increased its Humacyte (HUMA) stake by 39% in Q2 2026, buying an estimated $180 and bringing the position to 694 shares worth $542. The position accounts for ﹤0.01% of the portfolio, ranked #4227.

Fifth Third Bancorp first reported a position in HUMA in Q2 2024 and has held it in 9 quarters since. The position peaked at $5.17K in Q3 2024. 161 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Fifth Third Bancorp held 694 shares of Humacyte worth $542 as of Q2 2026.
  • Fifth Third Bancorp bought 194 Humacyte shares in Q2 2026, an estimated $180.
  • Humacyte made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #4227 holding.
  • Fifth Third Bancorp first reported a position in Humacyte in Q2 2024 and has held it in 9 quarters since.
  • Fifth Third Bancorp's Humacyte position peaked at $5.17K in Q3 2024.
  • 161 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.